Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Opus Genetics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q2 2025 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q3 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q4 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q1 2026 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q2 2026 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q3 2026 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q4 2026 | 1 | -$0.04 | -$0.04 | -$0.04 |
Opus Genetics, Inc. Earnings Date And Information
Opus Genetics, Inc. last posted its earnings results on Friday, March 28th, 2025. The company reported $-0.21 earnings per share for the quarter, topping analysts' consensus estimates of $-0.34 by $0.13. The company had revenue of 4.30 M for the quarter and had revenue of 10.99 M for the year. Opus Genetics, Inc. has generated $-2 earnings per share over the last year ($-2.15 diluted earnings per share) and currently has a price-to-earnings ratio of -0.52. Opus Genetics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based on prior year's report dates.
Opus Genetics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 2024 | N/A | -$1.33 | N/A | $3.40 M | $4.30 M |
| 09/30/2024 | Q3 2024 | N/A | -$0.29 | N/A | $2.28 M | $3.87 M |
| 06/30/2024 | Q2 2024 | N/A | -$0.30 | N/A | $2.45 M | $1.11 M |
| 03/31/2024 | Q1 2024 | N/A | -$0.29 | N/A | $5.34 M | $1.71 M |
| 12/31/2023 | Q4 2023 | -$0.05 | -$0.22 | -0.17 | $5.36 M | $1.69 M |
| 09/30/2023 | Q3 2023 | -$0.22 | $0.26 | 0.48 | $3.03 M | $11.94 M |
| 06/30/2023 | Q2 2023 | -$0.23 | -$0.24 | -0.01 | $2.43 M | $3.67 M |
| 03/31/2023 | Q1 2023 | -$0.15 | -$0.28 | -0.13 | N/A | $1.75 M |
| 12/31/2022 | Q4 2022 | $1.32 | $1.63 | 0.31 | N/A | $39.85 M |
| 09/30/2022 | Q3 2022 | N/A | -$0.22 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | -$0.28 | -$0.25 | 0.03 | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$0.35 | N/A | N/A | $0 |
| 12/31/2021 | Q4 2021 | N/A | -$0.35 | N/A | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$0.25 | N/A | N/A | $489.00 K |
| 06/30/2021 | Q2 2021 | N/A | -$0.52 | N/A | N/A | $100.00 K |
| 03/31/2021 | Q1 2021 | N/A | -$3.57 | N/A | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | $0.00 | N/A | N/A | $0 |
| 09/30/2020 | Q3 2020 | N/A | -$0.18 | N/A | N/A | $0 |
| 06/30/2020 | Q2 2020 | N/A | -$0.23 | N/A | N/A | $0 |
| 03/31/2020 | Q1 2020 | N/A | -$0.44 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Opus Genetics, Inc. Earnings: FAQ's
Opus Genetics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based offlast year's report dates.
In the previous quarter, Opus Genetics, Inc. (:IRD) reported $-0.21 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.34 by $0.13.
The conference call for Opus Genetics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Opus Genetics, Inc.'s latest earnings report can be read online.
Opus Genetics, Inc. (:IRD) has a recorded annual revenue of $10.99 M.
Opus Genetics, Inc. (:IRD) has a recorded net income of $-57,532,000.Opus Genetics, Inc. has generated $-2.15 earnings per share over the last four quarters.
Opus Genetics, Inc. (:IRD) has a price-to-earnings ratio of -0.52 and price/earnings-to-growth ratio is 0.01.